Mr. Richard M. Johnston is Independent Chairman of the Board of AtriCure Inc. He has served as one of directors since June 2002 and as Chairman of the Board since February 2005. From 2000 to 2010, Mr. Johnston served as a Managing Member of Camden Partners Holdings, LLC, a private equity firm, and he is now a Retired Member of that firm. Mr. Johnston currently serves as a director of BioMedical Enterprises, Inc., Lombard Medical Technologies PLC, Medivance, Inc. and Webmedx, Inc., all Camden Partners? portfolio companies of which Lombard Medical Technologies PLC is a publiclyheld company in the United Kingdom. During the last five years Mr. Johnston previously served as director of privatelyheld LipoScience Inc. and as Chairman of privatelyheld Picis, Inc. as well as a director of Pet DRx Corporationrationration, a publiclyheld company. From 1961 to 2000, Mr. Johnston was employed by The Hillman Company, an investment holding company with diversified operations, where he served from 1970 to 2000 as Vice President, Investments and as a director. From 1979 to 2003, Mr. Johnston was Chairman of the Board of The Western Pennsylvania Hospital and its successors, The Western Pennsylvania Healthcare System and West Penn Allegheny Health System
Independent Chairman of the Board
Age: 76 Chairman Since 2005 MBA
|Johnston received his B.S. from Washington and Lee University and his M.B.A. from The Wharton School, University of Pennsylvania.|
The company has return on total asset (ROA) of (7.62) % which means that it has lost $7.62 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (29.51) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 7.93 M in liabilities with Debt to Equity (D/E) ratio of 0.21 which may suggest the company is not taking enough advantage from borrowing. AtriCure Inc has Current Ratio of 4.19 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Entity SummaryAtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue. AtriCure Inc [ATRC] is traded on NASDAQ General Markets in USA. It is located in AtriCure, Inc.West Chester, OH and employs 230 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| ATRC Nasdaq
AtriCure Inc has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
AtriCure price boundaries
Promote AtriCure and Richard Johnston